GlassScriptPhysician profile
Jeffrey A Harter
NPI 1831326339
$3,208.41
in general payments reported to CMS, 2019-2025
21 companies · $669 in 2025
The $669 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $183 · 2021: $586 · 2022: $443 · 2023: $306 · 2024: $528 · 2025: $669.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,502.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $816.66 | 2019-2025 | Precision7, Total30, Dailies Total1 |
| Coopervision INC. | $482.30 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $358.60 | 2019-2025 | Acuvue |
| Mallinckrodt Hospital Products INC. | $221.40 | 2023-2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $195.32 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $188.24 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $120.43 | 2024-2025 | Xdemvy |
| Lkc Technologies, INC. | $113.75 | 2025 | |
| Bausch & Lomb Americas INC. | $99.04 | 2022-2025 | Infuse, Vyzulta, Xiidra |
| Rxsight INC | $95.88 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Oyster Point Pharma, INC. | $93.12 | 2022-2024 | Tyrvaya |
| Abbvie INC. | $82.81 | 2022 | |
| The Cameron-Ehlen Group, INC. | $77.07 | 2022 | |
| Ivantis, INC | $61.81 | 2021 | |
| Glaukos Corporation | $53.74 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $49.63 | 2023-2024 | Cequa |
| Alcon Research LLC | $36.66 | 2019 | |
| Abb Con-Cise Optical Group LLC | $20.85 | 2020 | |
| Biotissue Holdings INC. | $15.38 | 2019 | |
| Synergeyes, INC. | $13.50 | 2021 | |
| Allergan, INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Harter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.